References
Nakazato Y, Nakata Y, Hisaoka T, Sumiyoshi M, Ogura S, Yamaguchi H (1995) Clinical and electrophysiological characteristics of atrial standstill. Pacing Clin Electrophysiol 18:1244–1254
Fazelifar AF, Arya A, Haghjoo M, Sadr-Ameli MA (1995) Familial atrial standstill in association with dilated cardiomyopathy. Pacing Clin Electrophysiol 28:1005–1008
Mangrum JM, DiMarco JP (2000) The evaluation and management of bradycardia. N Engl J Med 342:703–709
Groenewegen WA, Firouzi M, Bezzina CR, Vliex S, van Langen IM, Sandkuijl L, Smits JP, Hulsbeek M, Rook MB, Jongsma HJ, Wilde AA (2003) A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res 92:14–22
Talwar KK, Radhakrishnan S, Chopra P (1988) Myocarditis manifesting as persistent atrial standstill. Int J Cardiol 20:283–286
Koshimizu TA, Komori S, Ishihara T, Kohno I, Umetani K, Sawanobori T, Ijiri H, Tamura K (2002) Restored atrial excitability after late recanalization in a patient with atrial standstill and acute myocardial infarction. Pacing Clin Electrophysiol 25:217–219
Park SR, Kwak CH, Kang YR, Seo MK, Kang MK, Cho JH, Ahn YJ, Hwang JY (2009) Implantable cardioverter-defibrillator implantation in a patient with atrial standstill. Yonsei Med J 50:156–159
El Menyar AA, Gendi SM (2006) Persistent atrial standstill in noncompaction cardiomyopathy. Pediatr Cardiol 27:364–366
Wolf-Puetz A, Wein M, Niehues R, Horlitz M, Kelm M, Klingel K, Kandolf R, Klein RM (2011) Multiple old myocardial scars and new onset of myocarditis in two young patients presenting with ventricular tachycardias and dilated cardiomyopathy. Clin Res Cardiol 100:253–260
Azaouagh A, Churzidse S, Konorza T, Erbel R (2011) Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update. Clin Res Cardiol 100:383–394
Zugck C, Franke J, Gelbrich G, Frankenstein L, Scheffold T, Pankuweit S, Duengen HD, Regitz-Zagrosek V, Pieske B, Neumann T, Rauchhaus M, Angermann CE, Katus HA, Ertl GE, Störk S (2012) Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure. Clin Res Cardiol 101:263–272
Böhm M, Voors AA, Ketelslegers JM, Schirmer SH, Turgonyi E, Bramlage P, Zannad F (2011) Biomarkers: optimizing treatment guidance in heart failure. Clin Res Cardiol 100:973–981
Suguta M, Hara K, Nakano A, Amano A, Hasegawa A, Kurabayashi M (2000) Serum atrial natriuretic peptide concentration is a useful predictor of atrial standstill in patients with heart failure. Jpn Circ J 64:537–540
Letsas KP, Efremidis M, Kounas SP, Pappas LK, Gavrielatos G, Alexanian IP, Dimopoulos NP, Filippatos GS, Sideris A, Kardaras F (2009) Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors. Clin Res Cardiol 98:208–212
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schroeter, M.R., Hasenfuß, G., Zabel, M. et al. Atrial standstill in a patient with progressive severe heart failure. Clin Res Cardiol 102, 473–476 (2013). https://doi.org/10.1007/s00392-013-0557-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-013-0557-2